A local vascular surgeon has highlighted a simple injection that could alleviate leg pain for those experiencing heaviness or ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Of note, however, at peak times, the oral DehydraTECH-tirzepatide-induced insulin levels were as much as approximately 100% higher than those from the Zepbound® injection. "Lexaria is delighted ...

Nintendo has finally lifted the lid on Switch 2 and... well, it looks an awful lot like the Switch. But there are subtle differences, a few obvious new additions, and still some intriguing ...

The filmmaker possessed a singular vision — and a knack for finding collaborators who could convey it. The filmmaker possessed a singular vision — and a knack for finding collaborators who ...

The drugmaker said sales of its flagship weight-loss drugs Mounjaro and Zepbound grew slower than expected in the fourth quarter. Lilly said it expects fourth-quarter revenue of roughly $13.5 ...

The company attributed the revision to lower-than-expected sales of tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity. “It’s always disappointing to miss your own ...

What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...

The pharmaceutical giant now projects $13.5 billion in revenue for the quarter, sparking concerns over the performance of its blockbuster weight-loss and diabetes drugs, Mounjaro and Zepbound. As of ...

Incretins such as glucagon-like peptide-1, or GLP-1, are used in diabetes and obesity drugs like Eli Lilly's Mounjaro and Zepbound. The stock (LLY) dropped 8.2% in morning trading, enough to make ...